Governor DeSantis Promotes Monoclonal Antibody Treatment For COVID-19 Patients
Dear Friends & Neighbors,
(Please click on red links & note magenta)
For updated global info & data on COVID-19, please click HERE.
For updated global data & graphs on COVID-19, please click HERE.
For COVID-19 cases and death counts in USA by state, please click HERE.
For COVID-19 cases in Florida via Florida COVID Action, please click HERE.
For COVID-19 cases in Florida, via Florida state government, please click HERE.
Gov. Ron DeSantis (R-FL) attends the opening of a monoclonal treatment site in Bonita Springs, Florida, in the video published on Aug. 20, 2021, “DeSantis Continues To Promote Monoclonal Antibody Treatment For COVID-19“, below:
Gov. DeSantis, TGH doctors discuss effectiveness of monoclonal antibody treatments in COVID patients, in the video published on Aug. 5, 2021, “Gov. DeSantis, TGH doctors discuss effectiveness of monoclonal antibody treatments in COVID patients“, below:
With hospital beds filling up across the state, Governor Ron DeSantis visited Tampa General Hospital (TGH), which, he said, is having great success with a treatment for COVID-19 that is not well known. TGH was the first in Florida to offer monoclonal antibodies. It is a highly effective therapy for people who contract COVID-19. More than 1,600 patients have received the antibody cocktails at the hospital’s infusion clinic at the Global Emerging Diseases Institute. The treatment has been shown to help reduce hospitalizations and prevent the worsening of COVID-19 symptoms. The key is getting the monoclonal antibodies early. The therapy works best right after you test positive, or within seven days of developing mild to moderate symptoms, in the video published on Aug. 5, 2021, “Florida Governor DeSantis promotes antibody treatment at Tampa hospital“, below:
Dr. Chirag Patel, an assistant professor of medicine at the University of Florida College of Medicine – Jacksonville and assistant chief medical officer at UF Health Jacksonville, discusses monoclonal antibody therapy for the treatment of COIVD-19, in the video published on Jan. 27, 2021, “Monoclonal Antibody Therapy for COVID-19 & Q&A – UF Health“, below:
Monoclonal antibody treatment can help high-risk patients with COVID-19, in the video published on Dec. 4, 2020, “Dr. Raymund Razonable – Monoclonal antibody treatment can help high risk patients with COVID 19“, below:
In the video published on Aug. 18, 2021, “What is monoclonal antibody treatment?“, below:
This video provides an overview of the use of antibodies for prevention of COVID-19 and how they might fill the gap for older adults or others who do not have optimal immune responses to a vaccine, in the video published on Nov. 4, 2020, “Using Monoclonal Antibodies for Prevention of COVID-19“, below:
To be eligible for monoclonal antibody therapy, patient needs to be over the age of 12, have mild or moderate symptoms, weighing more than 88 lbs and be high risk defined by one of the following criteria:
- Have a body mass index (BMI)>35
- Have chronic kidney disease
- Have diabetes
- Have immunosuppressive treatment
- Are currently receiving immunosuppressive treatment
- Are >=65 years of age OR
- Are >=55 years of age the cardiovascular disease, hypertension, or COPD/other chronic respiratory disease
You are not eligible for monoclonal anitbody therapy if you requiring supplemental oxygen above your baseline or sick enough to be hospitalized.
The monoclonal antibody therapy is infused through IV for about an hour. The complete therapy appointment takes about 3 hours. Allergic reactions may occur during or after the monoclonal antibody therapy. Although reactions and side effects are uncommon, some symptoms and side effects may appear as: fever, chill, nausea, headache, shortness of breath, low blood pressure, wheezing, swelling of your lips, face or throat, rash including hives, itching, muscle aches and dizziness. Side effects of getting any medicine by vein may include: brief pain, bleeding, bruising of the skin, soreness, swelling, and possible infection at the infusion site. Patients would be monitored for an hour after the infusion to assess for any reactions.
To see Governor Ron DeSantis’ Announcement for New Monoclonal Antibody Therapy Site in Orlando, please click HERE. (Orlando at Camping World Stadium, 1 Citrus Bowl Place, Orlando, FL., 9:00 am-7:00 pm daily, with capacity of over 300 patients.
To see more details about New Monoclonal Antibody Site in Orlando, please click HERE.
To find locations to receive monoclonal antibody treatments around the entire state, please visit floridahealthcovid19.gov.
To find state-supported monoclonal antibody treatment locations in Florida, please click HERE.
To make an appointment at a State of Florida site, please click HERE.
To find other monoclonal antibody sites, please click HERE.
To see the full video from the event, please click HERE.
Gathered, written, and posted by Windermere Sun-Susan Sun Nunamaker
More about the community at www.WindermereSun.com
Any comments, suggestions, concerns regarding this post will be welcomed at info.WindermereSun@gmail.com
We Need Fair Value of Solar
~Let’s Help One Another~
Please also get into the habit of checking at these sites below for more on solar energy topics: